Stock 4528 ONO PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Ono Pharmaceutical Co., Ltd.

Equities

4528

JP3197600004

Delayed Japan Exchange
Other stock markets
 02:00:00 2024-04-24 am EDT 		5-day change 1st Jan Change
2,294 JPY +0.17% Intraday chart for Ono Pharmaceutical Co., Ltd. -2.59% -8.80%
Mar. 21 ONO Pharmaceuticals, Co., Ltd. Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL CI
Mar. 14 Sibylla Biotech Enters Strategic Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. in Central Nervous System Disorders CI

Evolution of the average Target Price on Ono Pharmaceutical Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

d06fa03758512d46bb6d59d.tmLCCPllEowpKXiUnfMhB1ZOgfMdVeN7v3CHq7WN1Lk.jyCGZIEPS91dfBfu7LVWSDcr8pdwBo8W4Byw4ebfnsCDJfJBkRJc4k8ECw~2b3ee5f3872a35276fd82f24c8b79b2e

Analyst Recommendations on Ono Pharmaceutical Co., Ltd.

Jefferies Adjusts Ono Pharmaceutical’s Price Target to 2,400 Yen From 2,300 Yen, Keeps at Hold MT
Jefferies Adjusts Ono Pharmaceutical’s Price Target to 2,300 Yen From 2,500 Yen, Keeps at Underperform MT
Jefferies Downgrades Ono Pharmaceuticals to Underperform From Hold, Adjusts Price Target to 2,500 Yen From 3,000 Yen MT
Jefferies Downgrades Ono Pharmaceuticals to Hold From Buy, Adjusts Price Target to 3,100 Yen From 4,300 Yen MT
ONO Selected as Highest Rating A-List Company by CDP in Two Categories of 'Climate Change' and 'Water Security' in CDP 2022 AQ
ONO Selected as a Highest Rating A-List Company for Both 'Climate Change' and 'Water Security' in CDP 2021 AQ
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2,294 JPY
Average target price
2,656 JPY
Spread / Average Target
+15.75%
High Price Target
5,170 JPY
Spread / Highest target
+125.32%
Low Price Target
1,800 JPY
Spread / Lowest Target
-21.55%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Ono Pharmaceutical Co., Ltd.

Jefferies & Co.

Ratings for Ono Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 4528 Stock
  4. Consensus Ono Pharmaceutical Co., Ltd.